Literature DB >> 15372258

Chronic idiopathic axonal polyneuropathy revisited.

Nathalie R Rosenberg1, Marinus Vermeulen.   

Abstract

OBJECTIVE: To investigate whether several years after the diagnosis chronic idiopathic axonal polyneuropathy (CIAP), the cause of the neuropathy is still idiopathic.
METHODS: All outpatients were included in this study in which, between 1993-2000, with the same guideline for chronic neuropathy, the diagnosis CIAP was made. We checked whether the patients had been evaluated according to this guideline. We evaluated the clinical course in all patients and repeated questions on the family history. We also re-examined these patients. After recording these data, we decided whether or not the neuropathy remained idiopathic.
RESULTS: A total of 478 outpatients had been evaluated, of these 53 were diagnosed as CIAP. Of these the diagnosis remained CIAP in 27 (51%) patients. In 19 (36%) of the patients a wrong diagnosis was made, explained by not following the diagnostic guideline, and by not recognising hereditary neuropathies.
CONCLUSION: In half of the patients with the diagnosis CIAP, this diagnosis was changed after revision, including the family history of neuropathies. Therefore, in patients with the diagnosis CIAP, this diagnosis should be reconsidered. In addition the question should be whether the hereditary neuropathies have been excluded.

Entities:  

Mesh:

Year:  2004        PMID: 15372258     DOI: 10.1007/s00415-004-0499-8

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  17 in total

1.  Guide to development of practice guidelines.

Authors:  M A Kish
Journal:  Clin Infect Dis       Date:  2001-03-09       Impact factor: 9.079

Review 2.  Peripheral neuropathy.

Authors:  Richard A C Hughes
Journal:  BMJ       Date:  2002-02-23

3.  Characteristics of effective clinical guidelines for general practice.

Authors:  Jako S Burgers; Richard P T M Grol; Joost O M Zaat; Teun H Spies; Akke K van der Bij; Henk G A Mokkink
Journal:  Br J Gen Pract       Date:  2003-01       Impact factor: 5.386

Review 4.  Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force.

Authors: 
Journal:  Neurology       Date:  1991-05       Impact factor: 9.910

5.  Antibiotic guidelines and antibiotic use in adult bacterial meningitis in The Netherlands.

Authors:  Diederik van de Beek; Jan de Gans; Lodewijk Spanjaard; Marinus Vermeulen; Jacob Dankert
Journal:  J Antimicrob Chemother       Date:  2002-04       Impact factor: 5.790

6.  Chronic symmetric symptomatic polyneuropathy in the elderly: a field screening investigation in two Italian regions. I. Prevalence and general characteristics of the sample. Italian General Practitioner Study Group (IGPSG).

Authors: 
Journal:  Neurology       Date:  1995-10       Impact factor: 9.910

7.  Chronic idiopathic polyneuropathy presenting in middle or old age: a clinical and electrophysiological study of 75 patients.

Authors:  N C Notermans; J H Wokke; H Franssen; Y van der Graaf; M Vermeulen; L H van den Berg; P R Bär; F G Jennekens
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-10       Impact factor: 10.154

8.  Chronic polyneuropathy of undetermined cause.

Authors:  J G McLeod; R R Tuck; J D Pollard; J Cameron; J C Walsh
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-05       Impact factor: 10.154

9.  Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients.

Authors:  V G Fowler; L L Sanders; D J Sexton; L Kong; K A Marr; A K Gopal; G Gottlieb; R S McClelland; G R Corey
Journal:  Clin Infect Dis       Date:  1998-09       Impact factor: 9.079

10.  Chronic idiopathic axonal polyneuropathy: a five year follow up.

Authors:  N C Notermans; J H Wokke; Y van der Graaf; H Franssen; G W van Dijk; F G Jennekens
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-12       Impact factor: 10.154

View more
  6 in total

Review 1.  Drug therapy for chronic idiopathic axonal polyneuropathy.

Authors:  Janna Warendorf; Alexander Fje Vrancken; Ivo N van Schaik; Richard Ac Hughes; Nicolette C Notermans
Journal:  Cochrane Database Syst Rev       Date:  2017-06-20

2.  Neuromuscular manifestations in hereditary haemochromatosis.

Authors:  S F Wouthuis; C Th B M van Deursen; M P te Lintelo; C A M Rozeman; R Beekman
Journal:  J Neurol       Date:  2010-04-01       Impact factor: 4.849

3.  Yield of next-generation neuropathy gene panels in axonal neuropathies.

Authors:  Diana C Lee; Lois Dankwa; Christyn Edmundson; David R Cornblath; Steven S Scherer
Journal:  J Peripher Nerv Syst       Date:  2019-11-19       Impact factor: 3.494

Review 4.  Chronic idiopathic axonal polyneuropathy: a systematic review.

Authors:  Panagiotis Zis; Ptolemaios Georgios Sarrigiannis; Dasappaiah Ganesh Rao; Channa Hewamadduma; Marios Hadjivassiliou
Journal:  J Neurol       Date:  2016-03-09       Impact factor: 4.849

5.  Feasibility and cost efficiency of a diagnostic guideline for chronic polyneuropathy: a prospective implementation study.

Authors:  A F J E Vrancken; S Kalmijn; E Buskens; H Franssen; M Vermeulen; J H J Wokke; N C Notermans
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03       Impact factor: 10.154

6.  Omega-6 and omega-3 fatty acids predict accelerated decline of peripheral nerve function in older persons.

Authors:  F Lauretani; S Bandinelli; B Bartali; B Benedetta; A Cherubini; A D Iorio; A Blè; V Giacomini; A M Corsi; J M Guralnik; L Ferrucci
Journal:  Eur J Neurol       Date:  2007-07       Impact factor: 6.089

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.